Natural killer (NK) cell-mediated cytotoxicity: Differential use of TRAIL and Fas ligand by immature and mature primary human NK cells

被引:423
作者
Zamai, L [1 ]
Ahmad, M [1 ]
Bennett, IM [1 ]
Azzoni, L [1 ]
Alnemri, ES [1 ]
Perussia, B [1 ]
机构
[1] Thomas Jefferson Univ, Jefferson Med Coll, Kimmel Canc Inst, Philadelphia, PA 19107 USA
关键词
natural killer cells; differentiation; cytotoxicity; TRAIL; Fas ligand;
D O I
10.1084/jem.188.12.2375
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mature natural killer (NK) cells use Ca2+-dependent granule exocytosis and release of cytotoxic proteins, Fas ligand (FasL), and membrane-bound or secreted cytokines (tumor necrosis factor [TNF]-alpha)to induce target cell death. Fas belongs to the TNF: receptor family of molecules, containing a conserved intracytoplasmic "death domain" that indirectly activates the caspase enzymatic cascade and ultimately apoptotic mechanisms in numerous cell types. Two additional members of this family, DR4 and DR5, transduce apoptotic signals upon binding soluble TNF-related apoptosis-inducing ligand (TRAIL) that, like FasL, belongs to the growing TNF family of molecules. Here, we report th:lt TRAIL produced or expressed hy different populations of primary human NK cells is functional, and represents a marker of differentiation or activation of these, and possibly other, cytotoxic leukocytes. During differentiation NK cells, sequentially and differentially, use distinct members of the TNF family or granule exocytosis to mediate target cell death. Phenotypically immature CD161(+)/CD56(-) NK cells mediate TRAIL-dependent but not FasL- or granule release-dependent cytotoxicity, whereas mature CD56(+) NK cells mediate thr latter two.
引用
收藏
页码:2375 / 2380
页数:6
相关论文
共 37 条
[1]   REGULATION OF APOPTOSIS AND T-CELL ACTIVATION BY FAS-SPECIFIC MAB [J].
ALDERSON, MR ;
TOUGH, TW ;
BRADDY, S ;
DAVISSMITH, T ;
ROUX, E ;
SCHOOLEY, K ;
MILLER, RE ;
LYNCH, DH .
INTERNATIONAL IMMUNOLOGY, 1994, 6 (11) :1799-1806
[2]   Definition of a natural killer NKR-P1A(+)/CD56(-)/CD16(-) functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12 [J].
Bennett, IM ;
Zatsepina, O ;
Zamai, L ;
Azzoni, L ;
Mikheeva, T ;
Perussia, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (05) :1845-1856
[4]   Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-κB pathway [J].
Chaudhary, PM ;
Eby, M ;
Jasmin, A ;
Bookwalter, A ;
Murray, J ;
Hood, L .
IMMUNITY, 1997, 7 (06) :821-830
[5]  
CHONG ASF, 1989, J IMMUNOL, V142, P2133
[6]   Caspases: the executioners of apoptosis [J].
Cohen, GM .
BIOCHEMICAL JOURNAL, 1997, 326 :1-16
[7]   PRODUCTION OF HEMATOPOIETIC COLONY-STIMULATING FACTORS BY HUMAN NATURAL-KILLER CELLS [J].
CUTURI, MC ;
ANEGON, I ;
SHERMAN, F ;
LOUDON, R ;
CLARK, SC ;
PERUSSIA, B ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (02) :569-583
[8]   INDEPENDENT REGULATION OF TUMOR-NECROSIS-FACTOR AND LYMPHOTOXIN PRODUCTION BY HUMAN PERIPHERAL-BLOOD LYMPHOCYTES [J].
CUTURI, MC ;
MURPHY, M ;
COSTAGIOMI, MP ;
WEINMANN, R ;
PERUSSIA, B ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (06) :1581-1594
[9]   Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family [J].
DegliEsposti, MA ;
Smolak, PJ ;
Walczak, H ;
Waugh, J ;
Huang, CP ;
DuBose, RF ;
Goodwin, RG ;
Smith, CA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (07) :1165-1170
[10]  
Eischen CM, 1996, J IMMUNOL, V156, P2693